Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

about

Perioperative Management of Hilar Cholangiocarcinoma.Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer.Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging

P2860

Q35645739-7600427D-DD97-4CE2-9F74-6E8D39655D7F Q40399436-E203614E-42A8-4D85-B8A8-4249E93E1EBA Q57113192-3ACD0E71-2883-493A-99E5-3E0A94CF484E

P2860

Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Item

http://www.wikidata.org/entity/Q38222988

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

@en

type

Item

label

Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

@en

prefLabel

Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

@en

P1476

Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

@en

P2093

David Cosgrove

http://www.w3.org/2001/XMLSchema#string

Ihab Kamel

http://www.w3.org/2001/XMLSchema#string

Joseph M Herman

http://www.w3.org/2001/XMLSchema#string

Matthew J Weiss

http://www.w3.org/2001/XMLSchema#string

Neda Rastegar

http://www.w3.org/2001/XMLSchema#string

P2860

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system

Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients

Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis

Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage.

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer.

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study

Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma.

Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy.

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES.

P2888

s00423-014-1219-1

P304

679-692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00423-014-1219-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

399

http://www.w3.org/2001/XMLSchema#string

P50

Timothy Pawlik

P577

2014-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24962146

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

about

P2860

P2860

Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921